← FDA DRUG APPROVALS

FDA ANDA · ANDA202271

ACARBOSE

Sponsor: AVET LIFESCIENCES

APPLICATION
ANDA202271
TYPE
ANDA
ORIGINAL APPROVAL
2012-02-07
LATEST ACTION
2019-10-02
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ACARBOSEDiscontinued
ACARBOSE 50MG · TABLET · ORAL
ACARBOSEDiscontinued
ACARBOSE 100MG · TABLET · ORAL
ACARBOSEDiscontinued
ACARBOSE 25MG · TABLET · ORAL

Approval history

2019-10-02Labeling · Supplement 3 · standardAP
2013-05-13Labeling · Supplement 1AP
2012-02-07OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →